Akt1 inhibition promotes breast cancer metastasis through EGFR-mediated β-catenin nuclear accumulation

Wěi Li(Shougang (China)), Songqiang Xie(Henan University)

Cell Communication and Signaling

November 16, 2018

10.1186/s12964-018-0295-1

Cited by 46

Related Papers

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

|New England Journal of Medicine|2022|2.5k

HIF-1α pathway: role, regulation and intervention for cancer therapy

|Acta Pharmaceutica Sinica B|2015|1.9k

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

|The Lancet|2022|664

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients

|Science Translational Medicine|2016|416

Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer

|Journal of Clinical Investigation|2020|210